Clinical Trials
ERYTECH Announces Publication of its Phase 2b Trial of Eryaspase in Metastatic Pancreatic Cancer in the European Journal of Cancer
ERYTECH Pharma a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, announced that the full results from its Phase 2b trial evaluating eryaspase in metastatic pancreatic cancer are now published online in...
Clinical Trials
Anixa Biosciences collaborates with Urology Centers of Alabama on Cchek early prostate cancer detection study
Anixa Biosciences, Inc., a biotechnology company, announced a collaboration with Urology Centers of Alabama (UCA) in the Cchek early prostate cancer detection study. UCA will provide patient samples in Anixa's ongoing study, including support of clinical validation of Anixa's...
Clinical Trials
Biogen completes enrollment in phase 3 STAR study of gene therapy timrepigene emparvovec to treat inherited retinal disorder
Biogen Inc, a global biotechnology company, announced the enrollment of the last patient in the global phase 3 STAR clinical study, which is evaluating the investigational gene therapy timrepigene emparvovec (BIIB111/AAV2-REP1) for the treatment of choroideremia (CHM). CHM is...
Clinical Trials
CRISPR Therapeutics, Vertex Report First Data from Trials of Gene-Editing Treatment CTX001
CRISPR Therapeutics and Vertex Pharmaceuticals reported preliminary, mostly-positive safety and efficacy data from the first two patients enrolled in two Phase I/II trials assessing their CRISPR/Cas9 gene-edited therapy CTX001 for a pair of blood disorders—the first clinical trial of...
Clinical Trials
Signant Health and ActiGraphsimplify clinical trial activity and sleep monitoring for patients, sites, and sponsors with their new integration
Signant Health, formerly CRF Health and Bracket, is proud to announce that it has integrated its industry leading eCOA platform TrialMax®, with ActiGraph’s Centre Pointsystem. The integration, which includes ActiGraph’s FDA 510(k) cleared sensors, helps simplify the process of...
Clinical Trials
Thermo Fisher launches IonicX XRF Analyzer to identity ionic salts
Thermo Fisher Scientific has launched a new handheld X-ray fluorescence analyser called IonicX XRF Analyzer to help pharmaceutical and biopharmaceutical manufacturers to verify the identity of ionic salts in warehouses within seconds.
According to the life sciences company, the technology...
Clinical Trials
WFS awarded GDP certifications for Johannesburg and Cape Town pharma facilities
Worldwide Flight Services (WFS) has become the first air cargo handling company in South Africa to be awarded Good Distribution Practice (GDP) certifications for its temperature controlled pharma facilities, aligned to ISO9001:2015, in Johannesburg and Cape Town.
This latest WFS...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
